Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adverse drug reactions

J O'Donnell1

  • 1Rush Medical College, Chicago, Illinois.

Legal Medicine
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Adverse drug reactions cause significant patient harm. Enhanced monitoring and careful drug selection are crucial to mitigate risks associated with new and existing medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Complications in Chest Drain Insertion in the Emergency Department.

Irish medical journal·2025
Same author

All that Glitters is the Golden Patient: Improving staff morale through educational goal setting.

Irish medical journal·2025
Same author

Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices.

Thrombosis update·2024
Same author

Ligamentum teres reconstruction: indications, technique and minimum 1-year results in nine patients.

Journal of hip preservation surgery·2020
Same author

Canavirgella banfieldii Needlecast of Pinus strobus in Michigan.

Plant disease·2019
Same author

European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same journal

Medicare fraud regulations and the implications for joint ventures: are we working at cross purposes?

Legal medicine·1995
Same journal

Handwriting in health and disease.

Legal medicine·1995
Same journal

Forensic psychiatric testimony under the Federal Rules of Evidence.

Legal medicine·1995
Same journal

Alternative dispute resolution for medical malpractice actions: an efficient approach to the law and health care.

Legal medicine·1995
Same journal

Legal aspects of computerized medical records.

Legal medicine·1995
Same journal

A visitation with informed consent and refusal.

Legal medicine·1995
See all related articles

Area of Science:

  • Pharmacovigilance
  • Clinical Pharmacology
  • Patient Safety

Background:

  • Adverse drug reactions (ADRs) remain a significant cause of patient injury and morbidity.
  • Despite established protocols for drug prescription and administration, ADRs persist as a critical healthcare challenge.
  • New pharmaceutical agents introduce novel and often unknown risks that necessitate rigorous post-market surveillance.

Purpose of the Study:

  • To highlight the ongoing challenges posed by adverse drug reactions.
  • To emphasize the critical need for enhanced monitoring of new drugs.
  • To underscore the importance of comprehensive patient history in risk assessment.

Main Methods:

  • This study is a review of existing literature and clinical practice guidelines.

Related Experiment Videos

  • Analysis of reported cases of adverse drug reactions.
  • Discussion of risk factors contributing to ADRs.

    • Main Results:

    • Adverse drug reactions continue to cause substantial patient harm, irrespective of prescribing and administration safeguards.
    • Inadequate monitoring and selection of high-toxicity drugs exacerbate patient risks.
    • Poor patient history-taking practices contribute to the challenge of managing ADRs.

    Conclusions:

    • Continuous vigilance and improved monitoring systems are essential to minimize patient harm from medications.
    • Careful drug selection and thorough patient evaluation are paramount in preventing adverse drug events.
    • Addressing these challenges is vital to reduce morbidity and mortality associated with adverse drug reactions.